newsfilter
← Latest News
GlobeNewswire·

Immunomedics Reports First Quarter 2020 Results and Provides Corporate Update

Trodelvy™ received accelerated approval from FDA for third-line metastatic triple-negative breast cancer First patient treated with Trodelvy following successful commercial launch ASCENT study...